PROGRAMME

PROGRAMME

 

FRIDAY 19th SEPTEMBER 2014

 

8.00-9.00: Registration of participants, loading of presentations

 

9.00-9.30: Diego Ponzin, Rosa Sánchez de Vega and Corrado Teofili: Welcome and presentation of the conference.

 

9.30-10.30: MANAGEMENT OF GLAUCOMA IN CONGENITAL ANIRIDIA

Chairperson: Giorgio Marchini.

Panel of experts: Stefano Gandolfi and Maria Papadopoulos.

Speaker:

Peter Netland: State of the art, limits and future perspectives.

 

10.30-10.50: Coffee break

 

10.50-11.50: MANAGEMENT OF CATARACT IN CONGENITAL ANIRIDIA

Chairperson: Paolo Capozzi.

Panel of experts: Paolo Nucci and Maria Papadopoulos.

Speaker:

Dominique Brémond-Gignac: Cataract surgery in aniridic patients: review and personal experience.

 

11.50-12.30: THE POSTERIOR SEGMENT IN CONGENITAL ANIRIDIA

Chairperson: Paolo Capozzi.

Speakers:

Irene Gottlob: Foveal and optic nerve hypoplasia and nystagmus in patients with congenital aniridia.

Christopher D. Riemann: Congenital Aniridia:  A Posterior Segment Perspective.  A discussion of some worst case scenarios and treatment strategies which may provide hope.  Not all need be lost – at least not all the time.

 

12.30-14.00: Lunch

During the break, a separate meeting room will be available for those research scientists & clinicians who are interested in participating in a meeting, where the following topic will be discussed:
The Research in Aniridia: Opportunities and Challenges
Details of how to participate will be provided during the conference.

 

14.00-16.30: THE OCULAR SURFACE IN CONGENITAL ANIRIDIA

Chairperson: Paolo Rama.

Panel of experts: Vincent Borderie, Alessandro Lambiase, Maurizio Rolando, Berthold Seitz and Tor Paaske Utheim.
Speakers:

Conservative approaches:

  • José Santiago López-García: Aniridic keratopathy: conservative approaches.

Surgical approaches:

    • Juan Álvarez De Toledo: Lamellar and penetrating keratoplasty.
    • José de la Cruz: Boston KPRo Type I as viable alternative to visual rehabilitation in Aniridia patients. Advances and Limitations.
    • Julie T. Daniels: Cell therapy for regeneration of the corneal epithelium.
    • Ali R. Djalilian: Limbal Allograft Transplantation: How to maximize the outcomes in patients with aniridia.

 

16.30-18.20: CLINICAL ABSTRACT SESSION AND CASE REPORTS  I

Chairperson: Stefano Ferrari.

    • Kliuiev G: Modality of glaucoma treatment on adult patients with Aniridia
    • Pozdeyeva Na: Outcomes of surgical correction of congenital Aniridia
    • Casanave D: New colored diaphragm intraocular lens (IOL) with active pupillary zone (APZ) in the treatment of Aniridia
    • Moreno-Arrones Jp: Central corneal thickness in aniridics and relatives. A pilot study
    • Wowra B: Evaluation of corneal changes in confocal microscopy and OCT Visante in congenital Aniridia patients
    • Fagerholm P: Aniridia associated keratopathy: is it time to evaluate treatment?
    • Utheim Tp: Effect of storage temperature on the viability, phenotype, metabolism and morphology of cultured human oral keratinocytes
    • Mazzarolo M: Visual prognosis in 13 children with congenital Aniridia: our experience
    • Ingskog W: Living with Aniridia – One voice!

18.30: Transfer to Gala Dinner.

 

 

SATURDAY 20th SEPTEMBER 2014

 

8.30-9.00: Registration of participants, loading of presentations.

 

9.00-9.45: CONGENITAL ANIRIDIA: FROM GENETICS TO CLINICS

Chairperson: Giuseppe Damante.

Speaker:

Veronica van Heyningen: Genetic studies of aniridia help us to understand the underlying biology.

 

9.45-10.15: CLINICAL ABSTRACT SESSION AND CASE REPORTS II

Chairperson: Stefano Ferrari.

    • Ayuso C: Aniridia: guide for its genetic study, based on the experience at Hospital Fundacion Jimenez Diaz
      and Evaluation of chromosome 11p113 deletions in patients with syndromic Aniridia in Spain
    • Penco S: Genetic evaluation in subjects with Aniridia clinically defined
    • Rozet Jm: PAX6 mutations in French patients: an update

10.15-10.30: Coffee break

 

10.30-12.30: A SPECIAL EYE TO PATIENTS IN PEDIATRIC AGE

Chairpersons: Luisa Pinello and Elena Piozzi.

Speakers:

  • 10.30-10.55: Angelo Selicorni: Early diagnosis: the key roles of neonatologists and pediatricians.
  • 10.55-11.30: Barbara Käsmann-Kellner: Clinical management of aniridia – Dos and don’ts.
  • 11.30-11.55: Kristina Tornqvist: What is the role of the Pediatric Ophthtalmologist.
  • 11.55-12.20: Paola Facchin: Children with rare diseases and healthcare systems: from needs assessment to a comprehensive programme of care and assistance.

 

12.20: Best abstract acknowledgement

 

12.30-14.00: Lunch

During the break, a separate meeting room will be available for those research scientists & clinicians who are interested in participating in a meeting, where the following topic will be discussed:
The Research in Aniridia: Opportunities and Challenges
Details of how to participate will be provided during the conference.

 

14.00-17.20: OPHTHALMOLOGISTS AND RESEARCH SCIENTISTS MEET THE PATIENTS AND THEIR FAMILIES: AN OPPORTUNITY FOR BOTH TO LEARN

Chairperson: Domenica Taruscio.

 

Speakers:

  • 14.00-14.40: Veronica van Heyningen and Giuseppe Damante: Genetic counseling, prenatal diagnosis and IVF/pre-implant diagnosis.
  • 14.40-15.40: Dominique Brémond-Gignac, Paolo Capozzi, Giorgio Marchini, Peter Netland, Paolo Rama, Christopher D. Riemann and Tor Paaske Utheim: Summary on the outcomes of the conference
  • 15.40-16.20: Barbara Käsmann-Kellner, Luisa Pinello and Elena Piozzi: The role of the pediatrician and pediatric ophthalmologist: identifying congenital aniridia as soon as possible, assessing the visual function and following the child during daily life.

  • 16.20-16.40: Barbara Poli, Domenica Taruscio: European/international guidelines on Aniridia: a fundamental tool for physicians and patients.

  • 16.40-17.00: Rosa Sánchez de Vega: What to do when diagnosed with aniridia: the role of the patient associations.
  • 17.00-17.20: Jill A Nerby: Aniridia Foundation International: our experience in bringing together physicians, researchers and aniridia families and our research programs to improve understanding of aniridia and patient care.

 

17.20-17.40: Closing by Neven Milivojevic.